Heyman Tomas J. 4
4 · Akero Therapeutics, Inc. · Filed Jun 5, 2025
Insider Transaction Report
Form 4
Heyman Tomas J.
Director
Transactions
- Award
Common Stock
2025-06-03+9,398→ 9,398 total
Footnotes (1)
- [F1]These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs shall vest in full on the earlier of (i) June 3, 2026, and (ii) the next annual meeting of the Company's stockholders, subject to the director's continued service on the Board.